A naturalistic study of clozapine serum concentrations in psychiatric patients

Nordic Journal of Psychiatry

Volumn 50, Issue 5, 1994, Pages 413-418

  Olesen, Ole Vendelin ^a   Licht, Rasmus Wentzer ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BLOOD SAMPLING; CORRELATION FUNCTION; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG MONITORING; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; SCHIZOPHRENIA; SEX DIFFERENCE; TIME;

EID: 0029862265     PISSN: 08039488     EISSN: None     Source Type: Journal    
DOI: 10.3109/08039489409084967     Document Type: Article

References (30)

1. Agranulocytosis during treatment with clozapine
2. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome
3. Early response to clozapine in schizophrenia
4. Clinical management of clozapine patients in relation to efficacy and side-effects
5. Clozapine dose in the United States and Europe: implications for therapeutic and adverse effects
6. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking
7. Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patents
8. Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: A cross-sectional study
9. Clozapine-pharmacokinetic investigations and biochemical effects in man
10. Influence of patient-related variables on clozapine plasma levels
11. Clinical pharmacokinetics of clozapine in chronic schizophrenia patients
12. Disposition of clozapine and desmethyl clozapine in schizophrenic patients
13. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients
14. Plasma clozapine concentrations as a predictor of clinical response: a follow-up study
15. Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia
16. Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response
17. EEG alterations in patients treated with clozapine in relation to plasma levels
18. Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients
19. Antipsychotische Wirksamkeit im Verhältnis zum Plasmaspiegel von Clozapin
20. Seizures during clozapine therapy
21. Single vs multiple dose pharmacokinetics of clozapine in psychiatric patients
22. On-line fully automated determination of clozapine and desmethylclozapine in human serum by solid-phase extraction on exchangeable cartridges and liquid chromatography using a methanol buffer mobile phase on unmodified silica
23. Dose-related plas-malevels of clozapine: influence of smoking behaviour sex and age
24. Non-equilibrium method for the radioimmunoassay of clozapine in the presence of metabolites
25. Multiple-dose pharmacokinetics of clozapine in patients
26. A case report of cimetidin-induced clozapine toxicity
27. Car-bamazepine and plasma levels of clozapine
28. Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service
29. Clozapine treatment in Denmark: concomitant psychotropic medication and hematologic monitoring in a system with liberal usage practices
30. D1 D2 and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients